OncoCyte Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Net Income	-28.72	-73.42	-64.1	-29.93	-22.43	-15.75	-19.38	-11.17	-8.74	-4.99	Upgrade
Depreciation & Amortization	1.68	5.22	4.21	0.39	0.35	0.56	0.58	0.39	0.28	0.28	Upgrade
Share-Based Compensation	2.89	10.04	6.84	5.07	3	1.48	1.63	0.92	1.82	0.32	Upgrade
Other Operating Activities	-0.11	12.07	17.11	-1.51	-0.64	2.07	3.78	2.34	2.41	3.22	Upgrade
Operating Cash Flow	-23.33	-45.57	-35.94	-25.98	-19.72	-11.65	-13.39	-7.52	-4.23	-1.16	Upgrade
Capital Expenditures	0.07	-4.34	-2.25	-1.23	-0.92	-0.03	-0.09	-0.11	-0.5	-0.01	Upgrade
Acquisitions	-1.37	0	-11.71	-10.51	-11.25	0	0.93	0	0	1.33	Upgrade
Change in Investments	0.37	0	0	0	0	0	0	-0.08	0.82	0	Upgrade
Other Investing Activities	-	-	-	-0.01	-0.25	-	-	-	-	-	Upgrade
Investing Cash Flow	-0.93	-4.34	-13.96	-11.75	-12.42	-0.03	0.84	-0.18	0.32	1.32	Upgrade
Share Issuance / Repurchase	13.85	32.84	82.96	22.24	49.79	13.65	8.38	10.77	11.65	0	Upgrade
Debt Issued / Paid	-0.12	-1.43	-1.53	0.7	1.36	-1.18	1.58	-0.11	0	0	Upgrade
Other Financing Activities	-1.55	4.39	-3.07	-0.13	-3.29	-0.36	-	-0.77	-	-	Upgrade
Financing Cash Flow	12.19	35.81	78.36	22.8	47.87	12.11	9.97	9.88	11.65	0	Upgrade
Net Cash Flow	-12.07	-14.1	28.46	-14.93	15.74	0.43	-2.57	2.18	7.74	0.16	Upgrade
Free Cash Flow	-23.25	-49.91	-38.19	-27.21	-20.63	-11.68	-13.48	-7.63	-4.73	-1.17	Upgrade
Free Cash Flow Margin	-1547.04%	-5209.60%	-1737.40%	-2237.42%	-	-	-	-	-	-	Upgrade
Free Cash Flow Per Share	-3.04	-9.01	-8.59	-8.31	-8.04	-6.17	-8.93	-5.75	-4.50	-1.29	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).